Amit Chaudhari MD
@NeuroIRdoc
Followers
4K
Following
10K
Media
245
Statuses
2K
Neurologist | Neurointensivist | Neurointerventionalist | 🧑‍⚕️👨‍🍼👑
Joined September 2016
This is the most inspiring post I've read all year ❤️❤️. Each time we go to the procedure, we do absolutely everything we can to fight for our patient. Let's join and do the same to fight for our planet 🌎 and the future of our children 👩‍❤️‍👨
We're excited to see sustainability taking center stage in neurointervention! This @JNIS_BMJ study shows that there’s clear opportunity—and responsibility—for us to reduce waste and move toward greener practices. 🌱
0
1
5
#WorldStrokeDay in India celebrated with completion of Supernova SR trial!
newindianexpress.com
PUDUCHERRY: In a landmark achievement, the Jawaharlal Institute of Postgraduate Medical Education and Research (Jipmer) has successfully completed clinical tria
0
1
0
Why trust your doctor, when you can trust your politician! Very well written article about our new surgeon general Casey Means https://t.co/okGw59JH0D
nytimes.com
The anti-expert expert is up for the nation’s top doctor job.
1
0
2
Basking Biosciences has announced the first patients have been dosed in part B of its Phase 2 RAISE trial of BB-031, an investigational RNA aptamer targeting von Willebrand factor, in addition to the appointment of a new CEO @ShahidNimjee @juliacowens
https://t.co/nWpRXgNgxL
neuronewsinternational.com
Basking Biosciences has announced the first patients have been dosed in part B of its Phase 2 RAISE trial of BB-031, an investigational ribonucleic acid (RNA) aptamer targeting von Willebrand factor...
0
1
1
#NevaNet what an excellent excellent idea 💡 Conceptually makes total sense to just put a small filter at the end post-clot to prevent distal emboli or clot slippage .. so simple and intuitive, genius whoever thought of this 🫡. Love it @VESALIOcom
https://t.co/dswHECo6U8
2
1
4
A first-pass rate in a league of its own… – Dr. Paul Bhogal, UK A lower distal embolization rate… – Dr. Roland Schwab, Germany Discover NeVa NET — the next frontier in stroke thrombectomy. Watch the ESMINT STUDIO Session featuring Prof. Wim van Zwam, Dr. Paul Bhogal, and Dr.
0
2
5
A secondary analysis of the TEMPO-2 RCT found no significant improvement in outcomes for minor ischemic stroke patients treated with intravenous tenecteplase, regardless of the presence of disabling deficits. https://t.co/Se4XnZyuNE
0
26
71
Editorial: Recent trials show intravenous thrombolysis provides no clear benefit for patients presenting to the emergency department with mild stroke (NIHSS 0–5), highlighting the need for highly individualized treatment decisions. https://t.co/gn9gqYnhKe
0
42
137
Congrats @DanSahlein 👏🎉. You continue to inspire me..
Introducing #SNIS PSO Medical Director, Daniel Sahlein, MD! As a member of the board, Dr. Sahlein is looking forward to supporting the field through growth and innovation. Outside of work, he likes to spend time with his wife and three kids, exercise, hike, and ski!
0
1
3
How many times the annoying lint ends up on our wires and catheters .. The most exciting thing about this new "gauze" Swicker is not the reduced cost or absorption etc that they emphasizing, but that it's lint-FREE! https://t.co/BRwW1eL8vY
evtoday.com
October 14, 2025—Syntervention, Inc., a North Carolina-based company focused on eliminating preventable contamination in medical procedures, ann
0
0
0
Excited for this new 7-French Balloon guide catheter "Path BGC is a 7-F guide catheter engineered for trackability, stability, and distal access. It is designed for both transradial and transfemoral approaches" https://t.co/XroAv6828k
evtoday.com
October 15, 2025—Crossroads Neurovascular Inc. announced findings from the early clinical experience of the Path balloon guide catheter (BGC) du
0
1
4
"The 2023 NCD expanded coverage of CAS, which includes transcarotid artery revascularization (TCAR), to beneficiaries with ≥ 50% symptomatic stenosis and ≥ 70% asymptomatic stenosis, eliminating the “high risk for CEA” and “research trial” requirements" https://t.co/xKJshpXyJ9
evtoday.com
What physicians need to know about the expanded carotid artery stenting coverage, including choice of therapy, shared decision-making, and imaging requirements.
0
1
3
CARESTAR examines "treatment of patients with symptomatic non-stenotic carotid disease (SyNC) <50% and with high-risk plaque features for stroke recurrence".. Creating more business.. ? https://t.co/KUJrpdh16S
https://t.co/7XCxKkwaZ8
neuronewsinternational.com
NOTE: This video is ONLY available to watch in selected countries and geographies
0
1
1
Vertebral artery stenosis review https://t.co/CueA2Zqm8z "The true incidence of vertebral artery stenosis is not known due to the cases of asymptomatic stenosis of the vertebral artery"
pmc.ncbi.nlm.nih.gov
Vertebral artery stenosis (VAS) is the cause of approximately 20% of ischemic strokes in the posterior circulation. There are several causes of vertebral artery stenosis, including atherosclerosis,...
0
6
17
Neuro-oncology is entering a new era. New Frontiers in Neuro-Oncology highlights cutting-edge endovascular and intra-arterial approaches driving progress against complex brain and head and neck tumors at #SVIN25. Register here to join us: https://t.co/xODJWeQ7fG!
@DanielVelaMD
0
7
15
Prophylactic levetiracetam - despite demonstrating an acceptable safety profile - does not appear effective in modifying the frequency, severity or timing of post-acute ischaemic stroke #seizures, as per PROLEVIS trial data presented by Meena Chandu at #WSC2025
@WorldStrokeOrg
0
1
4
Congratulations @ShadiYaghi2 on leading this phenomenal work and having us on board.
ahajournals.org
0
4
9
Catheterization via the CSF? It is all fluid dynamics I guess.. would be interesting to see if this works in patients
jnis.bmj.com
Objective Aqueductal stenosis is a common cause of obstructive hydrocephalus, resulting in ventricular dilation and neurological deterioration. Standard treatments such as shunting, endoscopic third...
0
0
2
.@eva_mistry delivers concluding messages on preliminary results from the Phase 2 ARPEGGIO trial evaluating SCP776 - a novel cerebroprotective drug - in acute ischaemic stroke patients treated with #endovascular therapy #WSC2025 @WorldStrokeOrg
0
1
11